IP Library Granted Patent US 10,945,805
Granted Patent B2
US 10,945,805 · App. 16/786,042 · Granted Mar 16, 2021

Materials and methods for protecting against neuromas

Inventors: Curt Deister (Alachua, FL); Crystal Simon (Alachua, FL); Jennifer Faleris (Alachua, FL)
Assignee: AXOGEN CORPORATION
A61B90/08A61L31/005A61L31/04A61L31/048A61L31/06A61L31/14A61N1/0558A61B2090/0815A61L2430/32A61N1/05
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,945,805
App. No.
16/786,042
Granted
Mar 16, 2021
Kind
B2
Abstract

The subject invention provides devices and methods for alleviating discomfort associated with neuroma formation. The devices and methods of the invention effectively use the body's natural response of reconstructing implanted biomaterials to minimize the size of isolate, and protect a neuroma. In preferred embodiments, the subject device is a cylindrical cap, wherein the internal chamber of the cylindrical cap physically partitions the nerve to enable an arrangement of nerve fibers (as opposed to haphazardly arranged nerve fibers often produced in neuromas). Tabs arranged on the outside of the cap can be used to manipulate the cap into place on a nerve. The open end can also be configured with flaps that can be used to widen the open end for easier insertion of the nerve into the cap. In addition, the cap's material remodels into a tissue cushion after implantation, which protects the neuroma from being stimulated and inducing pain.

Claims (14)

1. A device comprising:

a body having an open proximal end and a closed distal end integrally formed with the body, wherein the body, including the closed distal end, defines an internal chamber, without openings other than at the proximal end, wherein the internal chamber is physically partitioned; and

a biomaterial that remodels into a tissue cushion after implantation;

wherein the body of the device is between about 1 mm and about 100 mm in length.

2. The device according to claim 1 , wherein the device comprises a biomaterial selected from the group consisting of high density polyethylene (HDPE), polyethylene glycol (PEG) hydrogel, and purified protein from human or other sources.

3. The device according to claim 1 , wherein the device comprises a biomaterial selected from the group consisting of small intestine submucosa (SIS), amnion, dermis, collagen, and decellularized fascia.

4. The device according to claim 1 , wherein the body is cylindrical in shape.

5. A method of using the device according to claim 1 , comprising inserting a nerve stump into the proximal end of the device.

6. The method of claim 5 . wherein a neuroma formed out of the inserted nerve stump is protected from external stimuli.

7. A method for preventing or limiting neuroma formation comprising inserting and securing a nerve stump into a device according to claim 1 .

8. The method of claim 7 , wherein neuroma formation is limited as compared to neuroma formation in the absence of said device.

9. A method comprising:

inserting and securing a nerve stump into a device according to claim 1 ; and

decreasing the pain associated with a neuroma formation as compared to the pain associated with a neuroma formation in the absence of said device.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 7, 2020
From: DEISTER, CURT; SIMON, CRYSTAL; FALERIS, JENNIFER
To: AXOGEN CORPORATION
Reel/Frame 053134/0534 →
Continuity (4)
Continuation 15496578 · Apr 25, 2017
Continuation In Part 14036405 · Sep 25, 2013
Provisional Application 61705251 · Sep 25, 2012
Related Publication 20200170747A1 · Jun 4, 2020